Tag: SRRA

Text size The deal comes ahead of GlaxoSmithKline’s planned spinoff of its consumer health division in July. AFP via Getty Images GlaxoSmithKline has agreed to buy US rare cancer therapy company Sierra Oncology for $ 1.9 billion in cash, as it looks to boost its portfolio of new specialty medicines. The UK drugmaker will pay … Read More “Sierra Oncology Stock Soars After $ 1.9 Billion Takeover by GSK” »

Text size AFP via Getty Images GlaxoSmithKline has agreed to buy US rare cancer therapy company Sierra Oncology for $ 1.9 billion in cash, as it looks to boost its portfolio of new specialty medicines. The UK drugmaker will pay $ 55 a share to buy San Mateo, California-based Sierra Oncology (ticker: SRRA), Glaxo (GSK) … Read More “Sierra Oncology Stock Soars After $ 1.9 Billion Takeover by GlaxoSmithKline” »